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Separation of Cardiac Glycosides by 
Thin-Layer Chromatography 
B. J. WHITE1 AND DENNIS 0ETH 
Abstract. Two structurally similar cardiac glycosides, 
digoxin and digitoxin, and their aglycones, digoxigenin and 
digitoxigenin, were separated by thin-layer chromatography 
using glass plates coated with silica gel H. Of 50 solvent 
systems tried, 15 were found to effect excellent separation of 
digoxin and digoxigenin. Separation of digoxin and digitoxin 
and their respective aglycones was achieved with three 
solvent systems. Spots were visualized with meta-dinitroben-
zene sodium hydroxide sprays. The lower limit of detection 
was 10 micrograms of glycoside per square centimeter. This 
method of separation should prove significant in identifying 
drug metabolites and determining toxicity levels of cardiac 
glycosides. 
HISTORY 
The cardiac glycosides, known commonly as digitalis, are 
steroids with sugar components that give them an unique effect 
on the heart of living organisms. These potent structures are im-
portant medically as some of the most respected and useful 
drugs in the medical armament against disease. 
Cardiac glycosides have long been used, both for their bene-
ficial and toxic effects. As early as 1500 B.C., there have been 
accounts of the Egyptians using these compounds for herb 
tnedicines. The Romans knew of their diuretic and emetic 
qualities, and the potent cardiac active drugs have been notori-
ously used as arrow poisons by natives throughout the ages. 
Not until William Withering, an English physician, published 
his text on the effects of digitalis in 1785 was much scientifically 
known about these compounds ( 1). His work, called An Account 
of the Foxglove and Some of Its Medicinal Uses: With practical 
remarks on dropsy and other diseases, contained standard prep-
arations for digitalis and discussed its effects on such diseases 
as dropsy and edema. He was not sure that it worked specifically 
on the heart muscle, but Withering was well aware of its effects 
on problems stemming from congestive heart failure. · 
Today, these drugs stand out in the physician's repertoire of 
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medicines. These pharmacologically dynamic steriods give 
strength to the weak or failing heart, improve its tonus and 
contraotility power, and regularize its rhythm. Congestive heart 
failure problems, such as edema, excessive accumulation of 
bodily fluids in the lower extremities, irregular heart rhythms, 
and even complete arrest can be treated ( 2). 
One must remember, however, that digitalis is a potent drug, 
and if not properly administered it can be ve1y toxic and 
poisonous. Knowledge of precise dosage amounts, the duration of 
toxic effects, and the individual patient's toJerance to these drugs 
is still inconclusive. The pharmacological researcher is thus con-
cerned with ascertaining rates of metabolism of the injected drug 
and conelating the percentage of recove1y of unaltered drug 
witji toxic effects. 
SOURCE 
The word "digitalis" comes from the two plant sources of 
these drugs, Digitalis lanata and Digitalis purpurea (purple 
foxglove). There are four main digitalis derivatives: digoxin, 
digitoxin, gitoxin, and gitalin. Digitoxin and gitoxin can be ex-
tracted from either plant source, while gitalin can be extracted 
only from D. purpurea and digoxin can only be extracted from 
D. lanata. The drugs are prepared from their raw state by mild 
alkaline hydrolysis to remove aceityl groups and enzymatic 
cleavage to remove glucose sugars. By successive alcoholic ex-
tractions, the drugs can be obtained in pure crystalline form for 
drug usage ( 3). 
STRUCTURE 
These digitalis derivatives are basically a 4-ringed steroid 
structure with an unsaturated 5-membered lactone ring. A sugar 
moiety consisting of three digitoxose sugars is connected by a 
glycosidic linkage to the steroid at the C-.S position. Digitoxose 
sugar is a 2, 6' -dideoxy aldohexose. All of the digitalis derivatives 
have methyl groups at C-10 and C-13. Digitoxin has a hydroxy 
group at C-14, digoxin has an hydro21.y group at C-12 and C-14, 
and gitoxin has a hydroxy group at C-14 and C-16. Gitalin is a 
mixture of inert ballast substances and the other steroids. 
The cardiac glycosides, so called because of their action on 
the heart by a sugar-bearing compound, can be reduced to their 
aglycone form (without sugar) by either acid hydrolysis or 
biological metabolism. The liver and heart are important organs 
of detoxification. The more sugar moieties the drug has, the more 
potent or toxic it is. As it successively loses one, two, or all 
three of its sugars, it is rendered less potent. 
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Figure 1. Detoxification of digoxin to its aglycone, digoxigenin. 
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The problem of the pharmacologist is to accurately separate 
the glycoside from its metabolite in the aglycone form. This 
glycoside to aglycone ratio is helpful in determining the rate of 
metabolism, the toxicity of the drug, and the duration of its 
effects. By applying this practically to medicine, proper dosage 
ratios can be adjusted for every patient's tolerance. 
The difficulty in separation arises from the similarity of 
molecular weights, chemical structure, and the fact that work 
is being done on very small quantities of biological substances. 
The researcher needs a special investigative tool for quick separa-
tion and identification. 
Thin-layer chromatography can serve as the answer to this 
problem. It has been shown to be useful for many steroid sep-
arations; it is fast, convenient, inexpensive, and it works par-
ticularly well on small quantities of recovered compounds. 
EXPERIMENTAL PROCEDURE 
In this study, 50 different solvent systems in varying concen-
trations were compared to establish which solvent systems might 
serve best for thin-layer chromatography of the cardiac glyco-
sides. Some of these solvents were reported in the literature, 
others have been known to worrk well on other steroid: systems 
( 4), and otherrs were first attempts ( 5). 
The two drugs, digoxin and digoxigenin, were used primarily 
for this investigation. (Drugs were supplied through the courtesy 
of Burroughs W ellcome & Company Pharmaceuticals, Tuckahoe, 
N.Y., and from Dr. James L. Spratt, Department of Pharma-
cology, College of Medicine, University of Iowa). A standard 
solution was prepared with 1 mg of drug to 1 ml of absolute 
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ethanol and stored in glass-stoppered flasks to prevent evapora-
tion or uptake of water. 
The chromatography equipment consisted of six cylindrical 
jars, about 30 cm high and 7 cm in diameter; these jars are of 
the type used to display biology specimens. Each jar had a 
ground glass rim that sealed well when covered with a plate 
glass top. A large glass block-type chamber was also used. 
The two types of chromatography plates were 3.8 mm thick, 
20 cm high, and 5 cm and 20 cm wide; they are found with the 
popular Desaga chromatography sets. A Desaga spreader was 
used for coating the plates. 
The plates were thoroughly cleaned and flushed with distilled 
water before use. The plates were then coated at a thickness of 
.25 mm with silica gel H according to the procedure of Stahl, 
and stornd in a cabinet with dessicant. No speciaJ activation or 
deactivation steps were taken. 
The chugs were spotted on the prepared plates with B-D 
Hypak disposable syringes (2~fcc 22 G Hf), one drop at a time. 
The spots were kept as small as possible to minimize the 
spreading during chromatography. Three separate spots were 
made on each plate: one 25 microliter spot of the 1 mg/ml 
standard solution of pure digoxin, one mixed spot of 25 micro-
liters each of digoxin and digozigenin, and one pure spot of 25 
microliters of digoxigenin. In this manner the central mixed spot 
could be observed for separation while the outer pure spots 
provided comparison. The spots were allowed to dry thoroughly 
before starting chromatography. 
The dry plates were set upright in a jar, 2.5 ml of solvent was 
added by pouring down the side of a stirring rod, and the jars 
were quickly covered. No prior equilibration time was allowed 
and no filter paper linings were considered to be necessary due 
to the small volume ·of the jars. After the solvent front had 
reached the top of the plate (generally one to two hours), the 
plate was removed and allowed to air dry. 
Meta-dinitrobenzene ( 10 grams in 200 ml benzene) and 16% 
NaOH were successively sprayed on the plates to develop the 
drugs. Spots were usually blue, brown, or orange and faded 
quickly. This spray is specific for the lactone ring in the steroid 
structure. Rf values of all three spots, their dimensions and other 
characteristics were noted immediately. 
RESULTS 
Of approximately 50 solvent systems, 15 were found to give 
excellent separation with an Rf difference between the digoxin 
and the digoxigenin greater than .10. Listed below are the better 
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ten of these solvents, in order of decreasing Rf difference. 
optimum solvent mixtures are given. 
Table 1. TLC of Cardiac Glycosides 
105 
The 
SOLVENT OPTIMUM Rf 
Digoxin 
Rf DIFFERENCE 
SYSTEM MIXTURE Digoxigenin RfG - Rfv 





Bu OH/ EtOAc ( 1 :20) .39 .22 
EtOAc / MeOH ( 4: 1) .51 .21 
EtOAc I benzene/ H20 ( 26.4: 15) .30 .20 
upper phase 
CHClR / BuOH ( 1:4) 
cyclohexane / EtOAc (2:8) 
ether / HCONMe~ ( 20: 1) 





















The smallest amount of digoxin that could be visually detected 
was 5.5 microiiters of the 1 mg/ml standard solution, or an 
amount corresponding to 5.5 micrograms of pure digoxin. A 
more positive limit for successful detection was 7.4 microliters 
or 7.4 micrograms of digoxin. This work was done with an 
EtOAc/MeOH ( 4:1) solvent system and the metadinitroben-
zene/NaOH spray. 
Digitoxin and its aglycone, digitoxigenin, were also successfully 
separated using some of the previous solvents. By preparing 
these drugs in a 1 mg/ml solution of absolute alcohol and 
spotting on the larger 20 cm by 20 cm plates, simultaneous 
separations of both digoxin, digitoxin, and their aglycones were 
achieved. Note that digoxin differs from digitoxin only by the 
presence of an extra hydroxy group at C-12 as do their respective 
aglycones, thus making them difficult to separate by other means. 
The three solvent systems below were found to be exceptionally 
good for these drug separations. 
Table 2. Comparative TLC of Cardiac Glycosides 
approximate Rf values 
CHClR / MeCOEt ( 1:4) 
CHClR /acetone (7.3) 
BuOH / EtOAc ( 1:9) 
digoxin digoxigenin digitoxin digitoxigenin 
.30 .62 .54 .89 
ns .~ .TI .oo 
.40 .62 .54 .69 
Although there are several reports in the literature of detecting 
these steroids by u.v. light, we failed to do so. Lamps of both 
long and short u.v. wavelengths were used both before and after 
chromatography, but never were the drugs visible. The silica 
gel H used as a coating may possibly be blamed for this failure. 
COMMERCIAL CIIBOMATOGRAPHY PAPER 
Eastman Chromagram sheets, type K301R2 and K301R with 
fluorescent indicator supplied by the Eastman Kodak Company 
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were tested in some of the better solvents. These sheets are pre-
coated plastic and are popular among experimenters because 
they are convenient and eliminate much of the labor needed to 
coat glass plates. Fair to good results were obtained in most 
cases, although the spots were less distinct, harder to visualize, 
faded quicker, and were subject to more tailing and spreading 
than their glass counterparts. 
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Correlating Data Which Fit the Gompertz 
Equation of Growth 
ROBERT G. SHEPPARD AND JAMES 0. 0sBURN1 
Abstract. The Gornpertz equation describes the decay of 
biological systems in which the rate of decrease of the con-
centration of an organism varies directly with its concentration 
and inverselv with the concentration of an inhibitor. The in-
hibitor concentration falls exponentially with time. Four meth-
ods are compared for correlating data on the destruction of 
Ascites tumor cells which fit the Gompertz equation: ana-
lytical, graphical, analog computer, and digital computer. 
The Gompertz equation (I) describes the rate of decay of a 
substance, where the decay is inhibited by a second substance 
which is also decaying. A common form of the equation as it is 





Here y is the concentration of the primary substance which 
is decaying, and x the concentration of the inhibitor. The con-
centration, x, can be expressed as a falling exponential 
(2) 
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